Jiangxi's First Fully Implanted Wireless Brain-Computer Interface Clinical Surgery Successfully Performed

Background

Brain-computer interface technology seeks to bridge the gap between neural activity and external actions, offering potential benefits for individuals with severe neurological injuries. In late 2025, a neurosurgery team at The First Affiliated Hospital of Nanchang University performed Jiangxi province's first clinical implantation of a fully implanted wireless brain-computer interface system. The procedure was reported in April 2026 and represented the second such "Triple-F" (fully implanted, fully wireless, fully functional) brain-computer interface clinical trial in China.

The patient was a 29-year-old man from Guangxi province who had sustained a high-level spinal cord injury in an accident, resulting in high paraplegia. Previously an art teacher, he participated in the trial conducted in collaboration with a domestic technology developer. Reports from Xinhua and provincial media detailed the case as part of broader efforts in China to advance neural interface applications for spinal cord injuries. The hospital's neurosurgery team, led by Professor Li Meihua, oversaw the procedure.

What was achieved

The surgery successfully implanted the Triple-F BCI system. Within one month postoperatively, the patient regained the ability to perform independent eating, writing, and drawing through thought-controlled movements. He was reported to have used the system to complete precise tasks including drawing a family portrait and writing messages such as "happy birthday."

By March 2026, the patient was documented using the interface to control an exoskeleton for family interactions, including touching his son. The case was described as verifying the system's stability and applicability across individuals, building on an earlier domestic trial. It established aspects of wireless, ultra-low latency, closed-loop control as a potential clinical standard and supported progression toward multi-center trials. The implantation took approximately three hours.

How it works

The technique involves surgical placement of a flexible cortical electrode array positioned subdurally on the surface of the motor cortex. This approach captures neural signals associated with movement intent without penetrating brain parenchyma, with the goal of preserving brain tissue safety. The system features a split design in which the battery module is implanted subcutaneously in the chest, distancing the heat-generating component from the brain.

Signals are decoded by algorithms, achieving an end-to-end latency below 50 milliseconds from intent detection to action. The fully wireless system includes built-in battery capacity, described as China's first and the world's second of its kind, supporting daily use via short wireless charging with no external cables. It integrates BCI-driven functional electrical stimulation (BCI-FES) to create a closed loop: cortical signals are decoded, bypassing the damaged spinal cord to trigger electrical stimulation of peripheral muscles, producing coordinated hand and finger movements. The surgical approach was modeled on established deep brain stimulation procedures.

What it means for international patients

The development highlights ongoing clinical research in neurosurgery and neurotechnology at major Chinese hospitals. The First Affiliated Hospital of Nanchang University has national clinical key specialty status in neurosurgery and participates in collaborative BCI research, including establishment of a clinical research ward. It maintains international research collaborations and is part of networks such as the China-Central and Eastern Europe Hospital Cooperation Alliance and serves as a National Health Commission international emergency rescue network hospital.

International patients considering care for neurological conditions or interested in advanced neurotechnologies should confirm current availability, eligibility criteria, and suitability for any clinical trials or procedures directly with the hospital. Specific patient selection for BCI systems remains tied to trial protocols, and individual assessments are required. No details on routine availability for medical tourists were reported in coverage of this specific case.

About the hospital

The First Affiliated Hospital of Nanchang University is located in Nanchang, the capital of Jiangxi province. Founded in 1939, it is a tertiary Grade A comprehensive public hospital affiliated with Nanchang University, functioning as its First Clinical Medical College. It operates multiple campuses including a headquarters and branches, with compiled beds reported between approximately 2,900 and over 5,600.

It is one of Jiangxi's largest hospitals by scale, number of departments, patient volume, and surgical capacity. It holds multiple national clinical key specialties, including neurosurgery, digestive medicine, burn care, respiratory and critical care medicine, cardiac and vascular surgery, emergency medicine, pain medicine, and intensive care. The hospital is approved by national authorities for human organ transplantation and assisted reproductive technologies and conducts extensive medical education, training, and research activities.